In a Canadian one-year prospective study, Alibhai et al. compared 77 ADT-treated non-metastatic PCa patients (94.8% on LH-RH analogues) with 82 non-ADT patients and 82 HCs [43]. This evidence concerns the gene GNRH1 and posterior cortical atrophy.